LY3090106 - SQ ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
46悪性関節リウマチ1

46. 悪性関節リウマチ


臨床試験数 : 4,356 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01925157
(ClinicalTrials.gov)
August 201315/8/2013A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)A Single-Dose, Multicenter, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3090106 in Healthy Subjects and Subjects With Rheumatoid ArthritisRheumatoid ArthritisBiological: LY3090106 - SQ;Biological: LY3090106 - IV;Biological: Placebo - SQEli Lilly and CompanyNULLCompleted18 Years80 YearsBoth43Phase 1Bulgaria;Moldova, Republic of;Poland;Romania;Hungary;United States